|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current assets: | |||||||
| Cash | |||||||
| Prepaid expenses | |||||||
| Total current assets | |||||||
| Investments held in Trust Account | |||||||
| Total assets | |||||||
| Liabilities, Class A common stock subject to possible redemption and Stockholders' Deficit: | |||||||
| Current liabilities: | |||||||
| Accounts payable | |||||||
| Accrued expenses | |||||||
| Working Capital Loans - related party | |||||||
| Franchise tax payable | |||||||
| Total current liabilities | |||||||
| Deferred underwriting commissions in connection with the initial public offering | |||||||
| Warrant liabilities | |||||||
| Total liabilities | |||||||
| Class A common stock, $0.0001 par value; 23,000,000 shares authorized, issued and outstanding, subject to possible redemption at $10.05 and $10.00 per share, at September 30, 2022 and December 31, 2021, respectively | |||||||
| Stockholders' Deficit: | |||||||
| Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding at September 30, 2022 and December 31, 2021 | |||||||
| Common stock | |||||||
| Class A Common Stock | |||||||
| Class B Common Stock | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Total Stockholders' Deficit | |||||||
| Total Liabilities, Class A common stock subject to possible redemption and Stockholders' Deficit |
Loading...